文献速递心境障碍精神分裂症与精神病性障碍焦虑、强迫与应激相关障碍

精神科药物研发:50年的失败与如何重振

Drug development in psychiatry: 50 years of failure and how to resuscitate it.
PubMed 文献 · Lancet Psychiatry · 2025-02-11

本文为个人观点文章,作者基于文献与咨询药企所获未发表知识,论述自1970年代以来精神科药物创新匮乏的原因,并提出重振建议。作者认为抑郁症、精神分裂症、焦虑障碍和注意缺陷多动障碍(ADHD)仍在使用1950年代偶然发现的药物类别,尽管已投入数千亿美元基于新神经科学靶点的研发尝试。

要点

  • 自1970年代以来精神科几乎没有创新性治疗,抑郁症、精神分裂症、焦虑障碍和ADHD仍用1950年代偶然发现的药物类别。
  • 作者认为精神疾病正成为全球主要健康负担,提出必须尽快纠正这一局面。
  • 作者观点基于已引用证据及咨询药企所获未发表知识,后者以意见形式呈现。

核心结论

  • 作者认为自1970年代以来精神科药物创新未像其他疾病领域那样取得进展,需尽快纠正这一局面。

研究设计与样本

  • 个人观点文章,作者为领域内研究者,证据多引用文献,咨询药企所获未发表知识以意见形式呈现。

主要发现

  • 过去50年医学科学取得显著进展,高血压、免疫疾病和癌症的药物治疗与1970年代根本不同且更多基于疾病特异性病理。
  • 精神科药物并非如此:尽管神经科学取得显著进展,自1970年代以来该领域开发的创新治疗极少。
  • 抑郁症、精神分裂症、焦虑障碍和ADHD仍在使用1950年代偶然发现的药物类别,尽管已投入数千亿美元基于新神经科学靶点的药物发现尝试。

临床怎么用

  • 作者认为精神疾病正成为全球主要健康负担,并提出必须尽快纠正精神科治疗创新未进展的局面。

局限性

  • 咨询药企所获未发表知识以意见形式呈现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension, immune disorders, and cancer are fundamentally different from those used in the 1970s, and are now more often based on disorder-specific pathologies. The same cannot be said for psychiatric medicines: despite remarkable advances in neuroscience, very few innovative treatments have been developed in this field since the 1970s. For depression, schizophrenia, anxiety disorders, and ADHD, pharmacological classes of medicines discovered through serendipity in the 1950s are still used despite hundreds of billions of US dollars being spent on drug discovery attempts based on new neuroscience targets. This Personal View presents my opinion on the reasons innovation in psychiatric treatment has not progressed as well as in other disorders. As a researcher in the field, I offer suggestions as to how this situation must be rectified soon, as by most analyses mental illness is becoming a major health burden globally. Most of my evidence is referenced, but where I have unpublished knowledge gained from consulting with pharmaceutical companies, it is presented as an opinion.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Nutt DJ. Drug development in psychiatry: 50 years of failure and how to resuscitate it. Lancet Psychiatry. 2025. PMID: 39952266. doi:10.1016/S2215-0366(24)00370-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。